Exciting new chapter...

I’m excited to start a new chapter as the CEO of Cynosure, a global company that is a leader in non-invasive medical aesthetics.  

Cynosure develops and manufactures best-in-class energy-based devices used by dermatologists, plastic surgeons, primary care physicians and medi-spas, helping people to achieve positive outcomes for skin revitalization, body sculpting, hair removal and women’s health.  The company’s key brands include PicoSure, SculpSure, TempSure, Icon, Elite and Mona Lisa Touch.

I am proud to join the remarkable team of people who have made Cynosure an industry leader and trusted by medical professionals and patients for the highest levels of efficacy and care.  

Together, I’m confident that we will continue to lead the market with best-in-class innovation, build our brand and broaden our portfolio, expand our geographic footprint, and accelerate growth and value creation for the company and our partners.

I look forward to leading Cynosure in this new era of accelerated growth for several reasons:

Reinvention – while this opportunity will allow me to leverage 30 years of experience in personal care, brand building, global marketing and turnarounds, it will also challenge me to learn a new business and global market, build new skills, and lead and inspire a great team.

Global Scope – Cynosure is a truly global company with operations on 6 continents and employees in 15 countries, with half of the business in the US and half outside the US.  This gives us unparalleled access to cross-cultural consumer insights and a deep understanding of global medical aesthetics business practices.

Innovation – I’m proud to be leading a business that has been a pioneer in the industry, driving best-in-class high technology devices to advance the quality of care in non-invasive medical aesthetics.  My commitment is to nurture this legacy, invest in new capabilities and further accelerate the delivery of best-in-class innovation. 

Entrepreneurial Speed – Cynosure is owned by Clayton, Dubilier & Rice, a leading private equity firm with extensive experience in the med-tech industry, the capacity to invest for growth and the ability to operate with speed to capture market opportunities.

Purpose – people are at the heart of everything we do, and our passion is to develop and deliver advanced medical aesthetic care, helping them achieve their desired skin revitalization, hair removal, body sculpting, and women’s health outcomes.

Transformation – Cynosure was founded in 1991 and went public in 2005.  It grew organically at a CAGR of +15% and added scale with accretive acquisitions as an independent public company.  In 2017, it was purchased for $1.6 billion by Hologic and it faced significant integration headwinds.  In December 2019, Cynosure was purchased by Clayton, Dubilier & Rice and it is being managed again as a stand-alone company with a significant growth strategy.  I’m confident that we will quickly operate with our historic entrepreneurial culture, transform the business and accelerate growth, both organically and through acquisition.

I look forward to the journey ahead, the learning it will engender, the personal and professional growth it will require for me and my team, and the promise of achieving great things together.  I’ll keep you updated along the way.

Warm regards -